Published in Lung Cancer on December 01, 2004
Survival prediction of stage I lung adenocarcinomas by expression of 10 genes. J Clin Invest (2007) 1.41
Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003. Value Health (2011) 1.22
New targeted molecular therapies for cancer: radiological response in intrathoracic malignancies and cardiopulmonary toxicity: what the radiologist needs to know. Cancer Imaging (2014) 0.95
Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients. PLoS One (2012) 0.93
ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer. Clin Cancer Res (2015) 0.88
Positron emission tomography-computed tomography in the management of lung cancer: An update. South Asian J Cancer (2013) 0.86
Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer. J Clin Oncol (2009) 0.84
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population. Clin Cancer Res (2009) 7.35
Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. J Clin Oncol (2009) 5.70
Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma. J Clin Oncol (2003) 2.36
Facts and indicators on palliative care development in 52 countries of the WHO European region: results of an EAPC Task Force. Palliat Med (2007) 2.30
Hypoxia, notch signalling, and prostate cancer. Nat Rev Urol (2013) 2.24
Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer. J Clin Oncol (2006) 1.56
Funding for palliative care programs in developing countries. J Pain Symptom Manage (2007) 1.51
Hospice and palliative care development in Africa: a multi-method review of services and experiences. J Pain Symptom Manage (2007) 1.37
Mapping levels of palliative care development: a global view. J Pain Symptom Manage (2008) 1.34
Perceptions of women medical students and their influence on career choice. Am J Surg (2002) 1.17
ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction. Proc Natl Acad Sci U S A (2002) 1.12
Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2002) 1.10
A decade of advances in treatment for advanced non-small cell lung cancer. Clin Chest Med (2011) 1.03
Noncoding RNAs in prostate cancer: the long and the short of it. Clin Cancer Res (2013) 0.95
Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors. Cancer (2006) 0.95
Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study. Int J Radiat Oncol Biol Phys (2004) 0.85
Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer. Int J Cancer (2012) 0.84
Official certification of doctors working in palliative medicine in Europe: data from an EAPC study in 52 European countries. Palliat Med (2007) 0.82
Manipulating the epigenome for the treatment of urological malignancies. Pharmacol Ther (2013) 0.81
IGFBP7 promoter methylation and gene expression analysis in prostate cancer. J Urol (2012) 0.81
Examining the inventory of interpersonal problems as a tool for conducting analogue studies of mechanisms underlying Borderline Personality Disorder. J Behav Ther Exp Psychiatry (2004) 0.81
Lost in translation: integrating medical interpreters into the multidisciplinary team. Oncologist (2008) 0.80
A phase I clinical trial of sequentially administered doxorubicin and topotecan in refractory solid tumors. Clin Cancer Res (2002) 0.80
Consensus building on access to controlled medicines: a four-stage Delphi consensus procedure. J Pain Symptom Manage (2013) 0.79
Does pre-operative estimation of oesophageal tumour metabolic length using 18F-fluorodeoxyglucose PET/CT images compare with surgical pathology length? Eur J Nucl Med Mol Imaging (2010) 0.79
Second line chemotherapy for NSCLC: establishing a gold standard. Lung Cancer (2002) 0.79
Carotid intima media thickness decreases after pancreas transplantation. Transplantation (2002) 0.78
In silico analysis and DHPLC screening strategy identifies novel apoptotic gene targets of aberrant promoter hypermethylation in prostate cancer. Prostate (2011) 0.78
Bariatric surgery using a network and teleconferencing to serve remote patients in the Veterans Administration Health Care System: feasibility and results. Am J Surg (2011) 0.77
Guidelines for the use of PET-CT in children. Nucl Med Commun (2008) 0.75
Point of view. Spine (Phila Pa 1976) (2002) 0.75
The talking cure: Schwartz Center Rounds foster compassion and collaboration. J Cancer Educ (2008) 0.75
Racism in the chemotherapy infusion unit: a nurse's story. Oncologist (2008) 0.75